COVID-19 and effects on osteoporosis management:​ the patient perspective from a National Osteoporosis Foundation survey

Singer, A. J.; Fuggle, N. R.; Gill, C. B.; Patel, A. R.; Medeiros, A. P.; Greenspan, S. L.

Affiliations

¹Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital and Georgetown University Medical Center, Washington, DC, USA

²Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA

³MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK

⁴Alan Turing Institute, London, UK

⁵National Osteoporosis Foundation, Arlington, VA, USA

⁶Department of Medicine, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Keywords

Keywords: Bone health; COVID-19; Fracture; Osteoporosis; Telemedicine

Links

DOI: 10.1007/s00198-021-05836-3

PubMed: 33558958

WoS: 000616020000002

History

Received: 2020-10-01

Accepted: 2021-01-06

Online: 2021-02-08

Cited Works (2)

Year	Entry
2019	Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. January 2019;30(1):79-92.
2009	van Geel TACM, van Helden S, Geusens PP, Winkens B, Dinant G-J. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis. January 2009;68(1):99-102.

Cited By (1)

Year	Entry
2022	Kocijan R, Stockinger T, Haschka J, Reichardt B, Resch H, Zwerina J, Behanova M. Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic. Bone. September 2022;162:116477.